Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer

Lung cancer is one of the deadliest and most common malignancies in the world, representing one of the greatest challenges in cancer treatment. Immunotherapy is rapidly changing standard treatment schedule and outcomes for patients with advanced malignancies. However, several ongoing studies are sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbone, Carmine, Piro, Geny, Di Noia, Vincenzo, D'Argento, Ettore, Vita, Emanuele, Ferrara, Miriam Grazia, Pilotto, Sara, Milella, Michele, Cammarota, Giovanni, Gasbarrini, Antonio, Tortora, Giampaolo, Bria, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885300/
https://www.ncbi.nlm.nih.gov/pubmed/31827379
http://dx.doi.org/10.1155/2019/7652014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885300/
https://www.ncbi.nlm.nih.gov/pubmed/31827379
http://dx.doi.org/10.1155/2019/7652014

Ejemplares similares